The expression of IL4I1, KYNA, KMO, IDO1, TDO2, 5-HT, and TPH1 is notably increased in CRC tissues, with strong correlations observed between these TRP metabolites and various clinical features [61–65, 84]. This evidence concerns the gene TDO2 and colorectal carcinoma.